GCO
Genesco Inc.
GCO has a slight edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
GCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GCO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.89 | -33% |
| Fair | 7.3x | $28.93 | -19% |
| Current | 9x | $35.78 | — |
| Forward | 12x | $35.78 | — |
| Expensive | 20x | $78.41 | +119% |
Historical ranges are pointers, not guarantees.
GCO's PE is in its expensive range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 12x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GCO's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | -22% |
| Q3 2026 | $3.96 | +$6.37 |
| Q2 2026 | $1.85 | +$3.38 |
| Q1 2026 | $1.25 | +$2.99 |
| Q4 2025 | -$0.15 | +$2.46 |
| Q3 2025 | -$2.41 | -$2.16 |
| Q2 2025 | -$1.53 | +$0.60 |
| Q1 2025 | -$1.74 | -$0.24 |
| Q4 2024 | -$2.61 | -$1.87 |
GCO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $529.9M | -3% |
| Q2 2026 | $487M | +2.8% |
| Q1 2026 | $799.9M | +7.2% |
| Q4 2025 | $616.2M | +3.3% |
| Q3 2025 | $546M | +4% |
| Q2 2025 | $474M | +3.6% |
| Q1 2025 | $745.9M | +0.9% |
| Q4 2024 | $596.3M | +2.9% |
GCO's revenue grew through 2021 and has held roughly level since: $530M last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +3.3 points |
| Q2 2026 | -3.2% | +2.8 points |
| Q1 2026 | 6.4% | +0.2 points |
| Q4 2025 | 1.4% | -0.3 points |
| Q3 2025 | -2.6% | -0.7 points |
| Q2 2025 | -5.9% | +1.1 points |
| Q1 2025 | 6.2% | +1.1 points |
| Q4 2024 | 1.7% | -0.2 points |
GCO has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60M | -16% |
| Q2 2026 | -$118.2M | +$1.7M |
| Q1 2026 | $163.5M | +58% |
| Q4 2025 | -$31.5M | +$4.7M |
| Q3 2025 | $71.7M | +262% |
| Q2 2025 | -$119.9M | -$79.8M |
| Q1 2025 | $103.3M | -4.2% |
| Q4 2024 | -$36.2M | -$23.4M |
GCO has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +489K shares |
| 1 year | +6.1% | +623K shares |
| 3 years | -3.8% | -427K shares |
| 5 years | -25% | -3.7M shares |
| Available history | -25% | -3.6M shares |
GCO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $12.6M |
| Q1 2025 | — |
| Q4 2024 | $440,000 |
GCO hasn't bought back shares in the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
GCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
GCO has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.5 | Neutral |
GCO's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GCO PE vs Consumer Cyclical Sector
| Metric | GCO | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 18x | 50% below |
| PE % | 68 | 47 | 21 pts above |
GCO is trading at 9.0x earnings, a 50% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1.1% below |
| 20 week MA | $35.6 | 0.4% above |
| 50 week MA | $32.9 | 8.9% above |
| 100 week MA | $30.9 | 16% above |
| 200 week MA | $30.6 | 17% above |
GCO has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $27.9 | -42% |
| 2021 | $27.9 | $59.8 | +114% |
| 2022 | $59.8 | $44.2 | -26% |
| 2023 | $44.2 | $35.2 | -20% |
| 2024 | $35.2 | $42.1 | +20% |
| 2025 | $42.1 | $25.6 | -39% |
| 2026 YTD | $25.6 | $35.8 | +40% |
GCO has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.